These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35688944)

  • 1. PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Liu Y; Ouyang L; Mao C; Chen Y; Li T; Liu N; Wang Z; Lai W; Zhou Y; Cao Y; Liu S; Liang Y; Wang M; Liu S; Chen L; Shi Y; Xiao D; Tao Y
    Oncogene; 2022 Jul; 41(27):3570-3583. PubMed ID: 35688944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.
    Shao M; Qi K; Wang L; Yu X; Zhang Q; Yu L; Wang L; Yang C; Fan L
    Cell Signal; 2024 Jun; 118():111148. PubMed ID: 38521179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
    Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
    Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
    Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
    J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
    Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
    J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
    Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
    Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis.
    Ji W; Zhang W; Zhang X; Ke Y
    Cell Signal; 2024 Sep; 121():111268. PubMed ID: 38909931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription.
    Wang YF; Feng JY; Zhao LN; Zhao M; Wei XF; Geng Y; Yuan HF; Hou CY; Zhang HH; Wang GW; Yang G; Zhang XD
    Acta Pharmacol Sin; 2023 Aug; 44(8):1712-1724. PubMed ID: 36829052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
    Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
    Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.
    Huang W; Chen K; Lu Y; Zhang D; Cheng Y; Li L; Huang W; He G; Liao H; Cai L; Tang Y; Zhao L; Pan M
    Neoplasia; 2021 Dec; 23(12):1227-1239. PubMed ID: 34768109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 13. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
    Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
    J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells.
    Zhou X; Wang Y; Li X; Zhou J; Yang W; Wang X; Jiao S; Zuo W; You Z; Ying W; Wu C; Bao J
    Redox Biol; 2024 Jul; 73():103182. PubMed ID: 38744192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.
    Feng Y; Zhang Y; Cai Y; Liu R; Lu M; Li T; Fu Y; Guo M; Huang H; Ou Y; Chen Y
    Cell Death Dis; 2020 Feb; 11(2):89. PubMed ID: 32015333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosome maintenance protein family member 6 mediates hepatocellular carcinoma progression by recruiting UBE3A to induce P53 ubiquitination.
    Zhang X; Bian S; Ni Y; Zhou L; Yang C; Zhang C; Sun X; Xu N; Xu S; Wang Y; Gu S; Zheng W
    Int J Biol Macromol; 2023 Sep; 248():125854. PubMed ID: 37460074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma.
    Jin D; Hui Y; Liu D; Li N; Leng J; Wang G; Wang Q; Lu Z
    Funct Integr Genomics; 2024 Feb; 24(1):29. PubMed ID: 38353724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.